Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-019-00752-6
Published Online: 2019-12-31
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, Marc
Hicks, Debbie
Patel, Dipesh
Patel, Vinod
McEwan, Phil
Dashora, Umesh
Article History
First Online: 31 December 2019